Alternative strategies for functionalizing CAR-T cells: engineering without genetic modification

Carolyn Porter, CEO, Cytoseek

 “As fifth generation CAR-T cells reach their limits for modifications facilitated by genetic engineering, new enhancement strategies independent of genetic modification are in development.”

Please enter your email to access content Read now